Andrew Pogozelski, MD
Basic profileAdvanced Heart Failure and Transplant Cardiology
Andrew Pogozelski is a Cardiology physician. OpenAlex indexes 6 publications with 234 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
320 E North Ave
Pittsburgh, PA 152124756
Telephone
412-359-6550Provider last certified this registry record 30 Sept 2020.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202519 payments$21,947openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202522 payments$18,188openpaymentsdata.cms.gov ↗
- Actelion Pharmaceuticals US, Inc.Program year202527 payments$17,750openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.5%Beta blocker15.5%Metoprolol Succinate54%Carvedilol25%Metoprolol Tartrate14%Atenolol3%Sotalol3%Part D<11 patientsStatin10.7%Atorvastatin Calcium66%Rosuvastatin Calcium19%Pravastatin Sodium12%Simvastatin4%Part D<11 patients+ 22 more classes in this area
Blood & clotting
15.9%Factor Xa inhibitor10.9%Eliquis77%Xarelto23%Part D≥139 patientsP2Y12 inhibitor2.7%Clopidogrel85%Brilinta15%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.2%SGLT2 inhibitor2.5%Jardiance67%Farxiga33%Part D≥31 patientsPotassium supplement2.5%Potassium Chloride89%Klor-Con M2011%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Local quantum size effect as seen by room-temperature 195Pt NMR in octanethiol-protected Pt nanoparticles
Chemical Physics Letters
2005 - Molecular dynamics of the compensatory response to myocardial infarct
Journal of Molecular and Cellular Cardiology
2004
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”